Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics
Open accessThe DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Abstract
Huntington’s disease (HD) is a progressive neurodegenerative disease characterized by preferential loss of neurons in the striatum in patients, which leads to motor and cognitive impairments and death that often occurs 10-15 years after the onset of symptoms. The expansion of a glutamine repeat (>36 glutamines) in the N-terminal region of huntingtin (HTT) has been defined as the cause of HD, but the mechanism underlying neuronal death remains unclear. Multiple mechanisms, including inflammation, may jointly contribute to HD pathogenesis. Altered inflammation response is evident even before the onset of classical symptoms of HD. In this review, we summarize the current evidence on immune and inflammatory changes, from HD animal models to clinical phenomenon of patients with HD. The understanding of the impact of inflammation on HD would help develop novel strategies to treat HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition to direct neuronal toxicity, HD pathogenesis is accompanied by significant neuroinflammation [192]. Brains impacted with HD exhibit increased microglial activation and elevated pro-inflammatory cytokine levels, including IL-6 and TNF-α [193,194].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · cited 1×
“Expansions varying from 36 to 39 CAG repeats may also result in HD, but with incomplete penetrance (1).”
BackgroundThe TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073 · cited 2×
“The R6/1 and R6/2 transgenic mice were the first transgenic model developed to study HD, which express exon 1 of the human HD gene with around 115 and 150 CAG repeats respectively (16).”
BackgroundGlutamine Repeats and Neurodegeneration
Zoghbi, H. Y., & Orr, H. T. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.217 · Cited by 1,309 · cited 1×
“The CAG repeat expansion encodes an expanded polyglutamine (polyQ) tract in mutant HTT that elicits neuronal loss in HD (4).”
BackgroundHistone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228 · cited 1×
“In vivo experiments have revealed that the ectopic overexpression of mutant human HTT (exon 1 with expanded CAG repeats) in the neural tissue of transgenic flies causes neurodegeneration (12, 13).”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 6×
“Furthermore, administering CX3CL1 protein was able to rescue R6/1 mice from long-term depression.”
BackgroundInfluentialDown-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022 · cited 1×
“Neuroinflammation can be modulated by neuron-glial signaling through various soluble factors, such as cluster of differentiation CD22 (80), CD47 (81), CD200 (82, 83), the family of CD300 receptors (84) and CX3CL1 (85).”
BackgroundCarter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Slow, E. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg169 · Cited by 800 · cited 2×
“Secondly, full-length transgenic mouse models carry mutant HTT in a yeast artificial chromosome (YAC) or bacterial artificial chromosome (BAC), which present a slow progression of the disease with comparable neuropathology and motor-related behavior changes (17, 18).”
BackgroundBjörkqvist, M., Wild, E. J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R. V., Benn, C. L., Soulet, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080178 · Cited by 650 · cited 7×
“The altered immune system function, not only in the CNS but also peripherally, has been implicated in HD pathogenesis (6, 37).”
BackgroundInfluential
Cited by
Adamu, A., Li, S., Gao, F., & Xue, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1347987 · Cited by 564
Self-citationIron imbalance in neurodegeneration
Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02399-z · Cited by 203
STAT3 Signaling Pathway in Health and Disease
Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al-Abbasi, F. A., Kumer, A., & Tabrez, S. S. M. (2025) · MedComm · doi:10.1002/mco2.70152 · Cited by 169
“Persistent STAT3 activation in HD has been associated withincreasedneuroinflammation,ahallmarkofthedisease[131, 144].”
Innate immune activation in neurodegenerative diseases
Castro-Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 162
The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions
Kerkis, I., da Silva, Á. R. D. B. P., & Araldi, R. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1400533 · Cited by 113
Metadata
- Authors
- Jia, Q., Li, S., Li, X.-J., & Yin, P.
- Affiliations
- Jinan University (CN)
- Corresponding author
- Li, Xiao-Jiang
- Yin, Peng
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-12-22
- Volume
- 13
- Pages
- 1088124-1088124
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9815700
- OpenAlex
- W4312188108
- Cited by
- 70
- References
- 118
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 21 · 2023: 6
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (2021ZT09Y007, 32270564, 81830032, 202007030008, 31872779, 2018B030337001)
- Guangdong Science and Technology Department (202007030008, 81830032, 31872779, 2018B030337001, 2021ZT09Y007)
- Fundamental Research Funds for the Central Universities (21622113)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- Huntington's disease, neuroinflammation, huntingtin, CAG repeat expansion, striatal degeneration, neurodegeneration mechanisms, immune response, clinical therapeutics
- MeSH terms
- Neuroinflammatory Diseases, Animals, Disease Models, Animal, Huntington Disease, Inflammation, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics. https://app.cochat.ai/papers/10.3389/fimmu.2022.1088124
- The paper
- Jia, Q., Li, S., Li, X.-J., & Yin, P. (2022). Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.1088124
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

